From: Exosomal transmission of viruses, a two-edged biological sword
Type of virus | Family | Intracellular transfer | Hijacking mechanism | Releasing mechanisms | Reference |
---|---|---|---|---|---|
Enveloped DNA viruses | |||||
Epstein-Barr Virus | Herpesviridae | ESCRT-dependent and ESCRT-independent pathways | TSG101, CD63, Syntenin‑1, Alix, and lipid rafts | Late endosomes | |
Kaposi's sarcoma-associated herpesvirus | Herpesviridae | ESCRT-dependent and ESCRT-independent pathways | Viral LMP1 | Late endosomes | |
Human Herpes virus-6 | Herpesviridae | ESCRT-independent pathway | CD63 and viral gB | Late endosomes | [172] |
Human Cytomegalovirus | Herpesviridae | ESCRT-independent, Vamp3-dependent pathways | VAMP3, viral pUL71 and UL99 | Late endosomes | |
Herpes simplex virus 1 | Herpesviridae | ESCRT-dependent pathway | ESCRT-III | Microvesicular budding, Autophagosome-mediated exit without lysis, Late endosomes | |
Non-enveloped DNA viruses | |||||
Adenoviruses 2 and 5 | Adenoviridae | ESCRT-independent pathway | Exosomal CD46, Lamp2c | Late endosomes, Microvesicular budding | |
Hepatitis B virus | Hepadnavirideae | ESCRT-dependent pathway | α-taxilin, viral LHBs, TSG101, 2-adaptin, Nedd4 | Late endosomes, Microvesicular budding | [245] |
Enveloped RNA viruses | |||||
Japanese encephalitis virus | Flaviviridae | ESCRT-dependent pathway | viral NS3, TSG101 | Late endosomes | |
Yellow fever virus | Flaviviridae | ESCRT-dependent pathway | Viral NS3 protein, Alix | Late endosomes | |
Dengue virus | Flaviviridae | ESCRT-dependent pathway | Viral NS3, Alix, viral protein E, Tsp29Fb | Late endosomes | |
West Nile virus | Flaviviridae | ESCRT-dependent pathway | Viral NS3, Alix and ESCRT | Late endosomes | [249] |
Zika virus | Flaviviridae | ESCRT-dependent pathway | Viral NS3 protein interacts with Alix | Late endosomes | |
Tick-borne encephalitis | Flaviviridae | ESCRT-dependent pathway | ND | Late endosomes | [249] |
Hepatitis C Virus | Flaviviridae | ESCRT-dependent pathway | Viral NS2 and NS5A proteins, Ago2, HSP90, and CD81 | Late endosomes | |
Human immunodeficiency virus-1 | Retroviridiae | ESCRT-dependent pathway | Viral Nef, Alix, viral Gag, and Syntenin | Late endosomes | |
Equine Infectious Anemia Virus | Retroviridiae | ESCRT-dependent pathway | Viral Gag, Alix | Late endosomes TGN is the assembly site | [257] |
Feline immunodeficiency virus | Retroviridiae | ESCRT-dependent pathway | Viral Gag, and Alix | Microvesicular budding | |
Human immunodeficiency virus-2 | Retroviridiae | ESCRT-dependent pathway | Viral Nef, Alix and viral Gag, and TSG-101 | Late endosomes, Microvesicular budding | |
Mouse Mammary Tumor Virus | Retroviridiae | ESCRT-dependent pathway | Viral Gag and NEDD4 | ND | [262] |
Murine Leukemia Virus | Retroviridiae | ESCRT-dependent pathway | Viral Gag and WWP1 | Late endosomes, Microvesicular budding | |
Porcine endogenous retrovirus | Retroviridiae | ESCRT-dependent pathway | Viral Gag, and WWP2 | Late endosomes | [265] |
Prototypic foamy viruses | Retroviridiae | ESCRT-dependent pathway | Viral Gag, TSG-101, and PPPI | Late endosomes, Microvesicular budding, trans-Golgi network | |
Mason–Pfizer monkey virus | Retroviridiae | ESCRT-dependent pathway | Viral Gag, TSG-101 and NEDD4 | Microvesicular budding | |
Human T cell leukemia virus type 1 | Retroviridiae | ESCRT-dependent pathway | Viral Gag, TSG-101 and NEDD4 | Late endosomes | |
Human endogenous retrovirus-K | Retroviridiae | ESCRT-dependent pathway | Viral Gag, TSG-101 | Late endosomes | |
Rous sarcoma virus | Retroviridiae | ESCRT-dependent pathway | Gag, NEDD4 and Alix | Late endosomes | |
Respiratory syncytial virus | Pneumoviridae | ESCRT-independent pathway | ND | Late endosomes | [46] |
Human Pegivirus, GB virus C | Flaviviridae | ESCRT-dependent pathway | hnRNPA2B1 protein | Late endosomes | |
Ebola virus | Flaviviridae | ESCRT-dependent pathway | Viral VP40, TSG-101, NEDD4, and VP24 | Late endosomes, Microvesicular budding | |
Marburg virus | Flaviviridae | ESCRT-dependent pathway | TSG-101, Viral VP40 and NEDD4 | Microvesicular budding | |
Lassa fever virus | Arenaviridae | ESCRT-dependent pathway | Z protein and TSG-101 | Microvesicular budding | |
Rabies Virus | Rhabdoviridae | ESCRT-dependent pathway | Viral M protein, ESCRTI, Alix, ESCRT III and VPS4 | Microvesicular budding | |
Vesicular stomatitis virus | Rhabdoviridae | ESCRT-dependent pathway | Viral M protein, TSG-101, and NEDD4 | Microvesicular budding | [286] |
Parainfluenza virus 5 | Paramyxoviridae | ESCRT-dependent pathway | Viral M protein, and VPS4 ATPase | Microvesicular budding | [287] |
Parainfluenza virus 3 | Paramyxoviridae | ESCRT-dependent pathway | Viral M protein | Microvesicular budding | [288] |
Newcastle disease | Paramyxoviridae | ESCRT-dependent pathway | Viral M protein and VPS4 ATPase | Microvesicular budding | [289] |
Mumps virus | Paramyxoviridae | ESCRT-dependent pathway | Viral M protein and VPS4 ATPase | Microvesicular budding | [290] |
Hepatitis E virus | Hepeviridae | ESCRT-dependent pathway | Viral pORF3, and TSG-101 | Late endosomes | |
Non-enveloped RNA viruses | |||||
Hepatitis A virus | Picornaviridae | ESCRT-dependent pathway | Viral VP2, Alix and VPS4B | Late endosomes | |
Coxsackievirus B | Picornaviridae | ESCRT-dependent pathway | LC3 | Microvesicular budding, Autophagosome-mediated exit without lysis and | [294] |
Poliovirus | Picornaviridae | ESCRT-dependent and independent pathways | Alix | Microvesicular budding, Autophagosome-mediated exit without lysis and | [165] |
Enterovirus 71 | Picornaviridae | ESCRT-dependent pathway | ND | Late endosomes | |
Reovirus | Reoviridae | ESCRT-dependent pathway | Rab5, Viral capsid protein P2 | Late endosomes, modified lysosomal organelle act as transporter virions to the plasma membrane | |
Rotavirus | Reoviridae | Probably ESCRT-dependent pathway | Probably VP4 interacts with lipid Rafts | Microvesicular budding | [150] |
Norovirus | Caliciviridae | Probably ESCRT-dependent pathway | Viral VP1, Phosphatidylserine lipid | Late endosomes | [174] |